President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases. 

The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.

"We're going to be able to make that drug available almost immediately," Trump said. 

The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.

He also tempered the president's optimism about the still-untested solution. 

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.  

"The therapies are something we could move on much faster potentially," Trump said. 

He claimed the administration "slashed red tape" to develop new vaccines and therapies.

The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks

"If we find that we need something, then we will do that," he said.  

Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak. 

The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.

"We continue our relentless effort to defeat the Chinese virus," Trump said.

Share:
More In Politics
New Twitter Research Reveals The Platform Content Amplifies 'Political Right'
According to new research by Twitter, the social media platform algorithm amplifies content from the "political right" rather than those on the left. The company says this data comes as the platform has been taking the time to research the implications of its algorithm and whether or not it has caused any "unknown harm". President and CEO of Media Matters for America Angelo Carusone, joined Cheddar to discuss more.
Virginia Governor's Race Down to a Dead Heat
Despite Joe Biden having won the state of Virginia in 2021 by 10 points, the race between his fellow Democrat Terry McAuliffe and Donald Trump-endorsed Republican Glenn Youngkin has tightened considerably down to the wire. Dave Levinthal, the deputy Washington bureau chief for Insider, joined Cheddar to give his analysis of the bellwether gubernatorial race in the year before the midterm elections.
Latest in the 2021 Virginia Gubernatorial Election
Laura Vozzella, local reporter for the Washington Post, joins Cheddar News to discuss the razor-thin edge Democrat Terry McAuliffe has over Republican candidate Glenn Youngkin in the 2021 Virginia gubernatorial election.
Load More